Nasdaq: NAMS, NAMSW
NewAmsterdam Pharma Company insiders
The officers, directors and 10% owners of NewAmsterdam Pharma Company N.V. who hold the most stock, valued at the live NAMS price.
$19.51
NAMS today −$230K (−1.17%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 3
- Their NAMS stock
- $21.4M
- Market value
- $2.34B
- Held by ranked insiders
- 0.92%
Insiders by value of NAMS holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Michael H. Davidson | Chief Executive Officer | 1,078,638 | $21.0M | 0.90% | 4943rd |
| 2 | William Lewis | Director | 10,360 | $202K | <0.1% | 1818th |
| 3 | John W. Smither | Director | 8,760 | $171K | <0.1% | 12738th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for NewAmsterdam Pharma Company; see each profile for the filing.